Cargando…
Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells
BACKGROUND: Mirk/Dyrk1B contributes to G0 arrest by destabilization of cyclin D1 and stabilization of p27kip1 to maintain the viability of quiescent human cancer cells, and it could be negatively regulated by mitogenic-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signa...
Autores principales: | Gao, Jingchun, Zhao, Yi, Lv, Yunyi, Chen, Yamin, Wei, Bing, Tian, Jianxin, Yang, Zhihai, Kong, Fandou, Pang, Jian, Liu, Jiwei, Shi, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575355/ https://www.ncbi.nlm.nih.gov/pubmed/23311607 http://dx.doi.org/10.1186/1475-2867-13-2 |
Ejemplares similares
-
Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013) -
The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer
por: GAO, JINGCHUN, et al.
Publicado: (2011) -
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
por: Deng, Xiaobing, et al.
Publicado: (2014) -
The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
por: Friedman, Eileen
Publicado: (2010) -
The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species
por: Deng, Xiaobing, et al.
Publicado: (2014)